RXILIENT Trademark Application Published for Opposition

ChangeBridge: Trademarks - Pharmaceuticals (Class 005)

Published March 26th, 2026

Detected March 27th, 2026

Summary

The USPTO has published the trademark application for 'RXILIENT' for pharmaceutical products, initiating a 30-day opposition period. The application, filed on November 19, 2025, covers a wide range of pharmaceutical preparations and dermatological products.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'RXILIENT' (TM79439298) for opposition. This publication initiates a period during which third parties may file an opposition to the registration of this mark. The application covers a broad spectrum of pharmaceutical products, including drugs, creams, medicaments, and preparations for the prevention and treatment of various conditions, particularly cancer and eye diseases, as well as dermatological products.

Companies involved in the pharmaceutical or dermatological sectors should be aware of this publication. While this is a trademark application and not a regulatory rule, it signifies a potential new market entrant or product line. Interested parties have 30 days from the publication date of March 26, 2026, to file an opposition if they believe the mark infringes on their existing rights or is otherwise objectionable. No immediate compliance actions are required for entities not directly involved in opposing the mark.

What to do next

Monitor trademark opposition period for 'RXILIENT' if relevant to existing intellectual property.

Source document (simplified)

← USPTO Trademark Applications

RXILIENT

Published for Opposition TM79439298 Kind: published Mar 26, 2026

Abstract

Pharmaceutical drugs; pharmaceutical creams; pharmaceutical medicaments in unit dosage form; pharmaceutical preparations and substances; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for application to the skin; pharmaceutical preparations for health care; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceuticals for ophthalmological use; biochemicals for pharmaceutical use; biological preparations for pharmaceutical purposes; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; preparations for the treatment of eye diseases; anti-cancer pharmaceutical preparations; capsules for veterinary pharmaceutical preparations; chemical preparations for pharmaceutical purposes; chemicals for pharmaceutical use; diagnostic agents for pharmaceutical use; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents that facilitate the delivery of pharmaceutical preparations; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; natural pharmaceutical preparations; chemical preparations for medical purposes; antibiotic dermatological products; antimicrobials for dermatologic use; barrier lotions for dermatological use; cortisone-based dermatological creams; creams for dermatological use; dermatologic preparations for medical purposes; dermatological pharmaceutical preparations; dermatological pharmaceutical products; external dermatological preparations; gels for dermatological use; hydrocortisone skin creams for dermatological use; injectable dermal fillers; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; pharmaceutical preparations for treating epidermal problems; pharmaceutical products for use in dermatology; skin patches for the transdermal delivery of pharmaceuticals; topical dermatological preparations for medical purposes; moisturisers [pharmaceuticals]; diagnostic preparations for medical use; medical preparations